CCNA2 fusions are only the second recurrent fusion event identified in hepatocellular carcinoma, after the PRKACA-DNAJB1 fusion characteristic of the rare fibrolamellar carcinoma subtype41. Here, CCNA2 is linked to fibrolamellar hepatocellular carcinoma.